This company has been acquired
Eargo Past Earnings Performance
Past criteria checks 0/6
Eargo's earnings have been declining at an average annual rate of -35.8%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been declining at an average rate of 2.6% per year.
Key information
-35.8%
Earnings growth rate
83.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -2.6% |
| Return on equity | -239.7% |
| Net Margin | -263.1% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Eargo: Straining To Be Heard
Aug 30Eargo jumps 77% following FDA rule on OTC hearing aids
Aug 16Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M
Aug 08Eargo completes $100M senior secured convertible notes issuance
Jul 05Eargo: A Binary Play On Hearing Loss
Dec 30Eargo Is A High Risk 'Option' With High Potential
Oct 08An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued
Jul 10
Eargo: I Am Slowly Starting To Listen
May 06What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?
Jan 16Eargo trades high afte hours on strong Q4 revenue, gross systems shipped
Jan 11Eargo: A Word Of Caution
Dec 15Eargo beats on revenue
Nov 19Revenue & Expenses Breakdown
How Eargo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 41 | -108 | 88 | 19 |
| 30 Jun 23 | 41 | -141 | 94 | 19 |
| 31 Mar 23 | 40 | -149 | 102 | 18 |
| 31 Dec 22 | 37 | -157 | 107 | 19 |
| 30 Sep 22 | 34 | -159 | 121 | 23 |
| 30 Jun 22 | 4 | -188 | 139 | 25 |
| 31 Mar 22 | 19 | -175 | 140 | 26 |
| 31 Dec 21 | 32 | -158 | 136 | 25 |
| 30 Sep 21 | 44 | -124 | 118 | 21 |
| 30 Jun 21 | 85 | -45 | 94 | 17 |
| 31 Mar 21 | 79 | -32 | 78 | 14 |
| 31 Dec 20 | 69 | -30 | 70 | 12 |
| 30 Sep 20 | 57 | -32 | 63 | 12 |
| 30 Jun 20 | 47 | -44 | 59 | 12 |
| 31 Mar 20 | 38 | -47 | 55 | 13 |
| 31 Dec 19 | 33 | -44 | 48 | 13 |
| 30 Sep 19 | 30 | -42 | 45 | 12 |
| 31 Dec 18 | 23 | -34 | 34 | 10 |
| 31 Dec 17 | 7 | -25 | 15 | 5 |
Quality Earnings: EAR is currently unprofitable.
Growing Profit Margin: EAR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EAR is unprofitable, and losses have increased over the past 5 years at a rate of 35.8% per year.
Accelerating Growth: Unable to compare EAR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EAR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).
Return on Equity
High ROE: EAR has a negative Return on Equity (-239.7%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/20 20:30 |
| End of Day Share Price | 2024/02/20 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eargo, Inc. is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Hopkins | BofA Global Research |
| Robert Marcus | J.P. Morgan |
| Lawrence Biegelsen | Wells Fargo Securities, LLC |